Harry Seifert

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Respiratory Syndrome Coronavirus

Top Venues

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Abdi Naficy, Adrienne Kuxhausen, Harry Seifert, Andrew Hastie, Brett Leav, Jacqueline Miller, Kate Anteyi, Agnes Mwakingwe-Omari
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial. Human vaccines & immunotherapeutics 20 (1) (2024)
Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer H Ku, Leticia I Vega Daily, Harpreet S Takhar, Jeannie Song, Elizabeth Chmielewski-Yee, O'Mareen Spence, Harry Seifert, Driss Oraichi, Hung Fu Tseng
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States. Human vaccines & immunotherapeutics 20 (1) (2024)
Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer H Ku, Leticia I Vega Daily, Harpreet S Takhar, Jeannie Song, Elizabeth Chmielewski-Yee, O'Mareen Spence, Harry Seifert, Driss Oraichi, Hung Fu Tseng
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States. Human vaccines & immunotherapeutics 20 (1) (2024)
Abdi Naficy, Adrienne Kuxhausen, Harry Seifert, Andrew Hastie, Brett Leav, Jacqueline Miller, Kate Anteyi, Agnes Mwakingwe-Omari
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial. Human vaccines & immunotherapeutics 20 (1) (2024)
Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer H Ku, Leticia I Vega Daily, Harpreet S Takhar, Jeannie Song, Elizabeth Chmielewski-Yee, O'Mareen Spence, Harry Seifert, Driss Oraichi, Hung Fu Tseng
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States. Human vaccines & immunotherapeutics 20 (1) (2024)
Abdi Naficy, Adrienne Kuxhausen, Harry Seifert, Andrew Hastie, Brett Leav, Jacqueline Miller, Kate Anteyi, Agnes Mwakingwe-Omari
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial. Human vaccines & immunotherapeutics 20 (1) (2024)
Abdi Naficy, Adrienne Kuxhausen, Harry Seifert, Andrew Hastie, Brett Leav, Jacqueline Miller, Kate Anteyi, Agnes Mwakingwe-Omari
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial. Human vaccines & immunotherapeutics 20 (1) (2024)
Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Jun Wu, Yanjun Cheng, Jennifer H Ku, Leticia I Vega Daily, Harpreet S Takhar, Jeannie Song, Elizabeth Chmielewski-Yee, O'Mareen Spence, Harry Seifert, Driss Oraichi, Hung Fu Tseng
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States. Human vaccines & immunotherapeutics 20 (1) (2024)
Fernanda Tavares-da-Silva, Olivia Mahaux, Lionel Van Holle, François Haguinet, Harry Seifert, Jens-Ulrich Stegmann
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology. Drug safety 43 (12) (2021)